Castle Biosciences Investor Relations Material
Latest events
Q2 2024
Castle Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Castle Biosciences Inc
Access all reports
Segment Data
Access more data
Net revenue by
Business area
Dermatologic
Other
Expenses by
Financials
Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Castle Biosciences is a provider of products that assesses the response of cancer patients to treatment. The company's products include Immunoscore non-invasive test, which measures changes in proteins expressed on the surface of a person's tumor; CastleTRAC, a diagnostic tool for assessing the tissue response in four types of cutaneous T-cell lymphomas (CTCL); and CastleMAP for measuring the immune reaction to a specific drug. Castle Biosciences, Inc., is based in Friendswood, Texas.
Key slides for Castle Biosciences Inc
Q2 2024
Castle Biosciences Inc
Q2 2024
Castle Biosciences Inc
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
CSTL
Country
🇺🇸 United States